Lambert–Eaton myasthenic syndrome associated with alemtuzumab administration
ConclusionAlemtuzumab treatment can result in the development of neurologic autoimmune conditions that could mimic MS progression.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Autoimmune Disease | Brain | Calcium | Multiple Sclerosis | Myasthenia Gravis | Neurology